G

Gossamer Bio
D

GOSS

11.370
USD
0.51
(4.70%)
Post Trading·11.480USD+0.110(+0.97%)
حجم التداول
10,424
الربح لكل سهم
-28
العائد الربحي
-
P/E
-0
حجم السوق
69,543,366
المقالات
المزيد

العنوان: Gossamer Bio Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).